The efficacy of semaglutide was not affected by age, gender, race, ethnicity, BMI at baseline, body weight (kg) at baseline, diabetes mellitus duration and renal impairment
Novo gets swept up in it
J Biol Chem , 84: 269320, 1929
Dias da Silva, Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions, Curr Mol Pharmacol, vol
Researchers continue monitoring symptoms throughout treatment because side effects may change as dose escalation continues
However, most side effects are mild to moderate and typically improve as your body adjusts